Other languages TELA Bio, Inc.

Equities

TELA

US8723811084

Real-time Estimate Cboe BZX Other stock markets 15:26:53 03/05/2024 BST			5-day change	1st Jan Change
4.74 ^USD	+2.38%		+6.97%	-28.10%

04-15	TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR	CI
03-22	Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR	04-15
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-21
TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2024	03-21
TELA Bio, Inc. Announces U.S. Commercial Launch of LIQUIFIX	03-21
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product	03-20
MiMedx Group, Inc. Enters into an Agreement with Tela Bio, Inc. to Obtain Exclusive Rights to Its Manufacturing and Supply Agreement	03-20
TELA Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
John Nosenzo Resigns as Member of the Board of Directors of TELA Bio, Inc	28/09/23
Advanced Medical to commercialise LiquiBandFix8 in US under Tela deal	18/09/23
Advanced Medical Solutions Partners with Tela Bio for US Commercialization of Surgical Device	18/09/23
Advanced Medical Solutions Group plc Signs Agreement with TELA Bio, Inc	18/09/23
TELA Bio, Inc. Announces U.S. Commercial Launch of OviTex PRS Long-Term Resorbable for Plastic and Reconstructive Surgery	16/08/23
TELA Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	09/08/23
TELA Bio, Inc. Reaffirms Revenue Guidance for Full Year 2023	09/08/23
TELA Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Tela Bio, Inc. Reaffirms Earnings Guidance for the Full Year 2023	11/05/23
TELA Bio Prices $45.1 Million Common Stock Offering	19/04/23
TELA Bio Launches Common Stock Offering; Shares Slide After-Hours	18/04/23
TELA Bio, Inc Provides Earnings Guidance for the Three Months Ended March 31, 2023	18/04/23
TELA Bio Says FDA Grants 510(k) Clearance for Soft Tissue Reconstruction Product	23/03/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages TELA Bio, Inc.

Equities

TELA

US8723811084

Other languages

Filters